Next Science Limited
NXSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20 | $49 | $89 | $177 |
| - Cash | $2 | $9 | $7 | $7 |
| + Debt | $2 | $1 | $1 | $0 |
| Enterprise Value | $21 | $41 | $83 | $170 |
| Revenue | $23 | $22 | $12 | $9 |
| % Growth | 2.9% | 89.4% | 30.9% | – |
| Gross Profit | $18 | $16 | $12 | $6 |
| % Margin | 80.8% | 73.2% | 101.6% | 66.4% |
| EBITDA | -$9 | -$14 | -$12 | -$9 |
| % Margin | -39.6% | -65% | -100.5% | -103% |
| Net Income | -$11 | -$25 | -$18 | -$9 |
| % Margin | -46.4% | -110.5% | -156.2% | -100.9% |
| EPS Diluted | -0.036 | -0.07 | -0.087 | -0.048 |
| % Growth | 47.8% | 20% | -82.9% | – |
| Operating Cash Flow | -$8 | -$15 | -$17 | -$8 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$9 | -$16 | -$18 | -$9 |